|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ettinger DS: Ten years of progress in
non-small cell lung cancer. J Natl Compr Canc Netw. 10:292–295.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Noone AM, Cronin KA, Altekruse SF,
Howlader N, Lewis DR, Petkov VI and Penberthy L: Cancer incidence
and survival trends by subtype using data from the surveillance
epidemiology and end results program, 1992–2013. Cancer Epidemiol
Biomarkers Prev. 26:632–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berindan-Neagoe I, Monroig Pdel C,
Pasculli B and Calin GA: MicroRNAome genome: A treasure for cancer
diagnosis and therapy. CA Cancer J Clin. 64:311–336. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin Y, Lv Y, Liang R, Yuan C and Zhang J,
He D, Zheng X and Zhang J: Four-miRNA signature as a prognostic
tool for lung adenocarcinoma. Onco Targets Ther. 11:29–36. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murakami T, Kikuchi H, Ishimatsu H, Iino
I, Hirotsu A, Matsumoto T, Ozaki Y, Kawabata T, Hiramatsu Y, Ohta
M, et al: Tenascin C in colorectal cancer stroma is a predictive
marker for liver metastasis and is a potent target of miR-198 as
identified by microRNA analysis. Br J Cancer. 117:1360–1370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Luo H, Xiao N, Duan J, Wang Z and
Wang S: Long noncoding RNA SChLAP1 accelerates the proliferation
and metastasis of prostate cancer via targeting miR-198 and
promoting the MAPK1 pathway. Onco Res. 26:131–143. 2018. View Article : Google Scholar
|
|
12
|
Hu Y, Tang Z, Jiang B, Chen J and Fu Z:
miR-198 functions as a tumor suppressor in breast cancer by
targeting CUB domain-containing protein 1. Oncol Lett.
13:1753–1760. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang J, Zhao H, Xin Y and Fan L:
MicroRNA-198 inhibits proliferation and induces apoptosis of lung
cancer cells via targeting FGFR1. J Cell Biochem. 115:987–995.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mirsadraee S, Oswal D, Alizadeh Y, Caulo A
and van Beek E Jr: The 7th lung cancer TNM classification and
staging system: Review of the changes and implications. World J
Radiol. 4:128–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barrett T, Troup DB, Wilhite SE, Ledoux P,
Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M and
Edgar R: NCBI GEO: Mining tens of millions of expression
profiles-database and tools update. Nucleic Acids Res.
35:D760–D765. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parkinson H, Kapushesky M, Shojatalab M,
Abeygunawardena N, Coulson R, Farne A, Holloway E, Kolesnykov N,
Lilja P, Lukk M, et al: ArrayExpress-a public database of
microarray experiments and gene expression profiles. Nucleic Acids
Res. 35:D747–D750. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han HS, Yun J, Lim SN, Han JH, Lee KH, Kim
ST, Kang MH, Son SM, Lee YM, Choi SY, et al: Downregulation of
cell-free miR-198 as a diagnostic biomarker for lung
adenocarcinoma-associated malignant pleural effusion. Int J Cancer.
133:645–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene Ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seike M, Goto A, Okano T, Bowman ED,
Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, et
al: MiR-21 is an EGFR-regulated anti-apoptotic factor in lung
cancer in never-smokers. Proc Natl Acad Sci USA. 106:12085–12090.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nymark P, Guled M, Borze I, Faisal A,
Lahti L, Salmenkivi K, Kettunen E, Anttila S and Knuutila S:
Integrative analysis of microRNA, mRNA and aCGH data reveals
asbestos- and histology-related changes in lung cancer. Genes
Chromosomes Cancer. 50:585–597. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bjaanaes MM, Halvorsen AR, Solberg S,
Jørgensen L, Dragani TA, Galvan A, Colombo F, Anderlini M,
Pastorino U, Kure E, et al: Unique microRNA-profiles in
EGFR-mutated lung adenocarcinomas. Int J Cancer. 135:1812–1821.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tai MC, Kajino T, Nakatochi M, Arima C,
Shimada Y, Suzuki M, Miyoshi H, Yatabe Y, Yanagisawa K and
Takahashi T: miR-342-3p regulates MYC transcriptional activity via
direct repression of E2F1 in human lung cancer. Carcinogenesis.
36:1464–1473. 2015.PubMed/NCBI
|
|
31
|
Robles AI, Arai E, Mathé EA, Okayama H,
Schetter AJ, Brown D, Petersen D, Bowman ED, Noro R, Welsh JA, et
al: An integrated prognostic classifier for stage I lung
adenocarcinoma based on mRNA, microRNA, and DNA methylation
biomarkers. J Thorac Oncol. 10:1037–1048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow
KM, Wang G, Li PK and Szeto CC: Glomerular and tubulointerstitial
miR-638, miR-198 and miR-146a expression in lupus nephritis.
Nephrology (Carlton). 17:346–351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Z, Chang H, Li Y, Zhang T, Zou J,
Zheng X and Wu J: MicroRNAs: Potential regulators involved in human
anencephaly. Int J Biochem Cell Biol. 42:367–374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bakre A, Mitchell P, Coleman JK, Jones LP,
Saavedra G, Teng M, Tompkins SM and Tripp RA: Respiratory syncytial
virus modifies microRNAs regulating host genes that affect virus
replication. J Gen Virol. 93:2346–2356. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi SY, Yun J, Lee OJ, Han HS, Yeo MK,
Lee MA and Suh KS: MicroRNA expression profiles in placenta with
severe preeclampsia using a PNA-based microarray. Placenta.
34:799–804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cardo LF, Coto E, Ribacoba R, Menéndez M,
Moris G, Suárez E and Alvarez V: MiRNA profile in the substantia
nigra of Parkinson's disease and healthy subjects. J Mol Neurosci.
54:830–836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qi B, Yao WJ, Zhao BS, Qin XG, Wang Y,
Wang WJ, Wang TY, Liu SG and Li HC: Involvement of microRNA-198
overexpression in the poor prognosis of esophageal cancer. Asian
Pac J Cancer Prev. 14:5073–5076. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bi C, Chung TH, Huang G, Zhou J, Yan J,
Ahmann GJ, Fonseca R and Chng WJ: Genome-wide pharmacologic
unmasking identifies tumor suppressive microRNAs in multiple
myeloma. Oncotarget. 6:26508–26518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vychytilova-Faltejskova P, Kiss I, Klusova
S, Hlavsa J, Prochazka V, Kala Z, Mazanec J, Hausnerova J, Kren L,
Hermanova M, et al: MiR-21, miR-34a, miR-198 and miR-217 as
diagnostic and prognostic biomarkers for chronic pancreatitis and
pancreatic ductal adenocarcinoma. Diagn Pathol. 10:382015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao JJ, Yang J, Lin J, Yao N, Zhu Y,
Zheng J, Xu J, Cheng JQ, Lin JY and MA J: Identification of miRNAs
associated with tumorigenesis of retinoblastoma by miRNA microarray
analysis. Childs Nerv Syst. 25:13–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of the tongue. Clin Cancer Res.
14:2588–2592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang S, Zhao Y and Wang L: MicroRNA-198
inhibited tumorous behaviors of human osteosarcoma through directly
targeting ROCK1. Biochem Biophys Res Commun. 472:557–565. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nie E, Jin X, Wu W, Yu T, Zhou X, Shi Z,
Zhang J, Liu N and You Y: MiR-198 enhances temozolomide sensitivity
in glioblastoma by targeting MGMT. J Neurooncol. 133:59–68. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang M, Wang J, Kong X, Chen H, Wang Y,
Qin M, Lin Y, Chen H, Xu J, Hong J, et al: MiR-198 represses tumor
growth and metastasis in colorectal cancer by targeting fucosyl
transferase 8. Sci Rep. 4:61452014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cui Z, Zheng X and Kong D: Decreased
miR-198 expression and its prognostic significance in human gastric
cancer. World J Surg Oncol. 14:332016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Marin-Muller C, Li D, Bharadwaj U, Li M,
Chen C, Hodges SE, Fisher WE, Mo Q, Hung MC and Yao Q: A
tumorigenic factor interactome connected through tumor suppressor
microRNA-198 in human pancreatic cancer. Clin Cancer Res.
19:5901–5913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang WT, Wang HL, Yang H, Ren FH, Luo YH,
Huang CQ, Liang YY, Liang HW, Chen G and Dang YW: Lower expressed
miR-198 and its potential targets in hepatocellular carcinoma: A
clinicopathological and in silico study. Onco Targets Ther.
9:5163–5180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gigante M, Pontrelli P, Herr W, Gigante M,
D'Avenia M, Zaza G, Cavalcanti E, Accetturo M, Lucarelli G,
Carrieri G, et al: miR-29b and miR-198 overexpression in
CD8+ T cells of renal cell carcinoma patients
down-modulates JAK3 and MCL-1 leading to immune dysfunction. J
Transl Med. 14:842016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liang YY, Huang JC, Tang RX, Chen WJ, Chen
P, Cen WL, Shi K, Gao L, Gao X, Liu AG, et al: Clinical value of
miR-198-5p in lung squamous cell carcinoma assessed using
microarray and RT-qPCR. World J Surg Oncol. 16:222018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Han HS, Jo YN, Lee JY, Choi SY, Jeong Y,
Yun J and Lee OJ: Identification of suitable reference genes for
the relative quantification of microRNAs in pleural effusion. Oncol
Lett. 8:1889–1895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ettinger DS, Wood DE, Aisner DL, Akerley
W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ,
Dobelbower M, et al: Non-small cell lung cancer, version 5.2017,
NCCN clinical practice guidelines in oncology. J Natl Compr Canc
Netw. 15:504–535. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zagryazhskaya A and Zhivotovsky B: miRNAs
in lung cancer: A link to aging. Ageing Res Rev. 17:54–67. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ozaki T and Nakagawara A: Role of p53 in
cell death and human cancers. Cancers (Basel). 3:994–1013. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wu S, Zhang G, Li P, Chen S, Zhang F, Li
J, Jiang C, Chen X, Wang Y, Du Y, et al: miR-198 targets SHMT1 to
inhibit cell proliferation and enhance cell apoptosis in lung
adenocarcinoma. Tumour Biol. 37:5193–5202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hausser J and Zavolan M: Identification
and consequences of miRNA-target interactions-beyond repression of
gene expression. Nat Rev Genet. 15:599–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nakanishi K: Anatomy of RISC: How do small
RNAs and chaperones activate Argonaute proteins? Wiley Interdiscip
Rev RNA. 7:637–660. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Duan D, Zheng KX, Shen Y, Cao R, Jiang L,
Lu Z, Yan X and Li J: Label-free high-throughput microRNA
expression profiling from total RNA. Nucleic Acids Res.
39:e1542011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ouyang T, Liu Z, Han Z and Ge Q: MicroRNA
detection specificity: Recent advances and future perspective. Anal
Chem. 91:3179–3186. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Li J, Yang H, Li Y, Liu Y, Chen S, Qi C,
Zhang Q, Lan T, He X, Guan XY and Wang L: microRNA-146
up-regulation predicts the prognosis of non-small cell lung cancer
by miRNA in situ hybridization. Exp Mol Pathol. 96:195–199. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van Schil PE, et al: International association for the study of
lung cancer/americanthoracic society/european respiratory society
internationalmultidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
